The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China.

Medicine (Baltimore) · 2015 · PMC5008507 · PMID 26656362

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

These results are similar to Poprach et al 10 in which they reported an association of borderline significance between improved PFS and skin toxicity during sorafenib treatment, and the presence of cutaneous toxicity was related to improved OS and PFS in sunitinib therapy.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.